| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/06/2001 | US20010048940 Supplying genes into mammal cells |
| 12/06/2001 | US20010048939 Cationic reagents of transfection |
| 12/06/2001 | US20010048928 Herpesvirus particles comprising fusion protein and their preparation and use |
| 12/06/2001 | US20010048920 Reovirus for the treatment of neoplasia |
| 12/06/2001 | US20010048919 Virus clearance of neoplastic cells from mixed cellular compositions |
| 12/06/2001 | US20010047966 Filtering sample of digested natural sources such as cells or cell fragments using filter the pore size of which decreases in direction of flow of sample through filter |
| 12/06/2001 | US20010047961 System and method for performing polynucleotide separations using liquid chromatography |
| 12/06/2001 | US20010047946 Card-shaped storage case for articles of daily use and/or consumer articles |
| 12/06/2001 | DE10115762A1 Preparing transgenic leguminous plants with increased protein content, useful e.g. as fodder, comprises transformation with specific genes, do not contain marker genes |
| 12/06/2001 | DE10027821A1 New intermediate in isoprenoid biosynthesis, useful in screening for potential herbicides, comprises mutant encoding-enzymes sequences for imparting herbicide resistance |
| 12/06/2001 | DE10026845A1 Triacylglycerol-Lipasen Triacylglycerol lipases |
| 12/06/2001 | DE10026758A1 Verfahren zur fermentativen Herstellung von D-Pantothensäure unter Verwendung corymeformer Bakterien A process for the fermentative preparation of D-pantothenic acid using bacteria corymeformer |
| 12/06/2001 | DE10026713A1 Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta Mutein of a chain of a protein from the superfamily of the growth factor TGF-beta |
| 12/06/2001 | DE10025920A1 Verfahren und Mittel zur Behandlung von Immunreaktionen am Auge Method and agent for the treatment of immune responses in the eye |
| 12/06/2001 | DE10025855A1 Producing transgenic mammal comprising reduced expression of DNAse I, useful for studying development of systemic lupus erythematosus and in drug screening |
| 12/06/2001 | DE10024569A1 Verfahren zur mikrobiellen Herstellung von Difructoseanhydrid-III, dafür einsetzbarer Mikroorganismus sowie Enzym mit Inulase-II-Aktivität und dafür kodierende DNA-Sequenzen A process for the microbial production of Difructoseanhydrid-III, but usable micro-organism and enzyme with inulase II activity, and DNA sequences coding for |
| 12/06/2001 | DE10024334A1 Verfahren zum Einbringen von Nukleinsäuren in eine Zelle (Transfektion) mittels Calciumphosphat sowie transfizierte Zelle A method for introducing nucleic acids into a cell (transfection) by means of calcium phosphate as well as transfected cell |
| 12/06/2001 | DE10017675A1 Verfahren zur Identifizierung und Isolierung von Genomfragmenten mit Kopplungsungleichgewicht A process for the identification and isolation of genomic fragments with linkage disequilibrium |
| 12/06/2001 | CA2423502A1 Triacylglycerol lipases from arabidopsis thaliana |
| 12/06/2001 | CA2414207A1 Adjuvant preparation for the induction of specific immunity |
| 12/06/2001 | CA2414125A1 Bartonella henselae virb operon and proteins encoded thereby |
| 12/06/2001 | CA2413995A1 Pseudotype retroviral vectors containing membrane proteins having hemagglutinin activity |
| 12/06/2001 | CA2413855A1 Surface for the immobilisation of ligands |
| 12/06/2001 | CA2413838A1 Redeposition or backstain inhibition during stonewashing process |
| 12/06/2001 | CA2411667A1 Ghrelin analogs |
| 12/06/2001 | CA2411655A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | CA2411404A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | CA2411304A1 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/06/2001 | CA2411040A1 Therapeutic anti-melanoma compounds |
| 12/06/2001 | CA2410981A1 Adenovirus particles with mutagenized fiber proteins |
| 12/06/2001 | CA2410950A1 Methods for detecting target nucleic acids using coupled ligation and amplification |
| 12/06/2001 | CA2410949A1 Novel target genes for diseases of the heart |
| 12/06/2001 | CA2410947A1 Methods for mediating gene suppresion by using factors that enhance rnai |
| 12/06/2001 | CA2410912A1 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | CA2410903A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | CA2410895A1 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | CA2410883A1 Methods for isolating and using fungal hemolysins |
| 12/06/2001 | CA2410865A1 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | CA2410762A1 Feline hepatocyte growth factor |
| 12/06/2001 | CA2410754A1 Phosphorylated polypeptides and uses related thereto |
| 12/06/2001 | CA2410736A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | CA2410734A1 Dnas encoding mammalian histamine receptor of the h4 subtype |
| 12/06/2001 | CA2410726A1 Structure-based methods for assessing amino acid variances |
| 12/06/2001 | CA2410665A1 Modified bovine adenovirus having altered tropism |
| 12/06/2001 | CA2410624A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 12/06/2001 | CA2410543A1 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens |
| 12/06/2001 | CA2410523A1 Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides |
| 12/06/2001 | CA2410516A1 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 12/06/2001 | CA2410515A1 Method of identifying and/or isolating stem cells |
| 12/06/2001 | CA2410514A1 Compositions and methods for identifying agents which modulate pten function and pi-3 kinase pathways |
| 12/06/2001 | CA2410489A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | CA2410480A1 Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
| 12/06/2001 | CA2410470A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | CA2410436A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/06/2001 | CA2410419A1 Improved methods of transfection |
| 12/06/2001 | CA2410265A1 Lyophilizable and enhanced compacted nucleic acids |
| 12/06/2001 | CA2410263A1 Purification of a triple helix formation with an immobilized oligonucleotide |
| 12/06/2001 | CA2410087A1 Mammalian protein phosphatases identified by in-silico analysis |
| 12/06/2001 | CA2410084A1 Transporters and ion channels |
| 12/06/2001 | CA2410051A1 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 12/06/2001 | CA2410033A1 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 12/06/2001 | CA2410015A1 Methods of transducing neural cells using lentivirus vectors |
| 12/06/2001 | CA2409417A1 Improved nucleic acid modifying enzymes |
| 12/06/2001 | CA2409311A1 Regulators of apoptosis |
| 12/06/2001 | CA2409193A1 Maize glutamine synthetase gene promoter |
| 12/06/2001 | CA2409191A1 Therapeutic compounds |
| 12/06/2001 | CA2408406A1 Cutinase variants |
| 12/06/2001 | CA2406939A1 Thermostable reverse transcriptases and uses thereof |
| 12/06/2001 | CA2401974A1 Dna expression vectors and methods of use |
| 12/06/2001 | CA2400777A1 Process for the fermentative preparation of l-threonine |
| 12/06/2001 | CA2396667A1 Apparatus and method for separating and purifying polynucleotides |
| 12/05/2001 | EP1160334A2 Probe for diagnosing infectious disease arising from Pseudomonas aeruginosa |
| 12/05/2001 | EP1160328A1 Frame adjust linkers |
| 12/05/2001 | EP1160327A2 Novel proteolytic enzymes and their use in detergents |
| 12/05/2001 | EP1160326A1 Mutant PLK protein and gene encoding the same |
| 12/05/2001 | EP1160325A1 Avermectin aglycon synthase genes |
| 12/05/2001 | EP1160323A1 5T4 tumour-associated antigen for use in tumour immunotherapy |
| 12/05/2001 | EP1160322A2 Human melanocyte stimulating hormone receptors |
| 12/05/2001 | EP1160321A1 Kidney Injury Novel Gene-1: Isolation and therapeutic applications |
| 12/05/2001 | EP1160320A1 Use of hTAFII80 and isoforms thereof for inducing apoptosis |
| 12/05/2001 | EP1160319A2 Antisense-oligonucleotides for the treatment of immunosuppressive effects of transforming growth factor-beta (TGF-beta) |
| 12/05/2001 | EP1160318A2 Medicament for treatment of Duchenne muscular dystrophy |
| 12/05/2001 | EP1160256A2 Monoclonal antibody specific for beta-A4 peptide |
| 12/05/2001 | EP1160255A1 Monovalent antibody fragments |
| 12/05/2001 | EP1160254A1 Human vanilloid receptor-like proteins |
| 12/05/2001 | EP1160253A1 A gene encoding a polypeptide having pre-B cell growth-supporting ability |
| 12/05/2001 | EP1159702A2 Computer-implemented nucleic acid isolation method and apparatus |
| 12/05/2001 | EP1159603A1 Raman optrode processes and devices for detection of chemicals and microorganisms |
| 12/05/2001 | EP1159457A1 T cell receptor vbeta beta-jbeta) sequence and methods for its detection |
| 12/05/2001 | EP1159455A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 12/05/2001 | EP1159454A2 Polynucleotide sequencing method |
| 12/05/2001 | EP1159441A2 Delivery of nucleic acids and proteins to cells |
| 12/05/2001 | EP1159440A2 Compositions and methods for recombinant adeno-associated virus production |
| 12/05/2001 | EP1159439A2 Enhanced system for construction of adenovirus vectors |
| 12/05/2001 | EP1159438A1 Means and methods for fibroblast-like or macrophage-like cell transduction |
| 12/05/2001 | EP1159437A2 Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins |
| 12/05/2001 | EP1159436A1 Agrobacterium-mediated transformation of cotton with novel explants |
| 12/05/2001 | EP1159435A1 Multigene expression vectors for the biosynthesis of products via multienzyme biological pathways |
| 12/05/2001 | EP1159434A2 Herbicide target genes and methods |
| 12/05/2001 | EP1159433A1 Translation regulation system and methods for use thereof |